Corvus Pharmaceuticals Inc (CRVS)
1.96
+0.28
(+16.67%)
USD |
NASDAQ |
May 08, 16:00
2.09
+0.13
(+6.63%)
After-Hours: 20:00
Corvus Pharmaceuticals Max Drawdown (5Y): 95.28% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 95.28% |
| March 31, 2024 | 95.28% |
| February 29, 2024 | 95.28% |
| January 31, 2024 | 95.28% |
| December 31, 2023 | 95.28% |
| November 30, 2023 | 95.28% |
| October 31, 2023 | 95.28% |
| September 30, 2023 | 95.28% |
| August 31, 2023 | 95.28% |
| July 31, 2023 | 95.28% |
| June 30, 2023 | 95.28% |
| May 31, 2023 | 95.28% |
| April 30, 2023 | 95.28% |
| March 31, 2023 | 95.28% |
| February 28, 2023 | 94.95% |
| January 31, 2023 | 94.95% |
| December 31, 2022 | 94.95% |
| November 30, 2022 | 94.95% |
| October 31, 2022 | 94.95% |
| September 30, 2022 | 94.95% |
| August 31, 2022 | 94.95% |
| July 31, 2022 | 94.95% |
| June 30, 2022 | 94.95% |
| May 31, 2022 | 94.39% |
| April 30, 2022 | 92.40% |
| Date | Value |
|---|---|
| March 31, 2022 | 92.20% |
| February 28, 2022 | 92.20% |
| January 31, 2022 | 92.20% |
| December 31, 2021 | 91.86% |
| November 30, 2021 | 91.86% |
| October 31, 2021 | 91.86% |
| September 30, 2021 | 91.86% |
| August 31, 2021 | 91.86% |
| July 31, 2021 | 91.86% |
| June 30, 2021 | 91.86% |
| May 31, 2021 | 91.86% |
| April 30, 2021 | 91.86% |
| March 31, 2021 | 91.86% |
| February 28, 2021 | 91.86% |
| January 31, 2021 | 91.86% |
| December 31, 2020 | 91.86% |
| November 30, 2020 | 91.86% |
| October 31, 2020 | 91.86% |
| September 30, 2020 | 91.86% |
| August 31, 2020 | 91.86% |
| July 31, 2020 | 91.86% |
| June 30, 2020 | 91.86% |
| May 31, 2020 | 91.86% |
| April 30, 2020 | 91.86% |
| March 31, 2020 | 91.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.60%
Minimum
May 2019
95.28%
Maximum
Mar 2023
92.29%
Average
91.86%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Cyclacel Pharmaceuticals Inc | 99.50% |
| Arbutus Biopharma Corp | 96.69% |
| Oragenics Inc | 98.92% |
| Relmada Therapeutics Inc | 95.67% |
| MAIA Biotechnology Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.01 |
| Beta (5Y) | 1.056 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 139.2% |
| Historical Sharpe Ratio (5Y) | -0.1454 |
| Historical Sortino (5Y) | -0.5133 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.82% |